Cargando…
A US Time and Motion Pilot Study of Nebulized COPD Therapy in an Inpatient and a Long-Term Care Setting
INTRODUCTION: There is a lack of quantitative data on healthcare professionals’ (HCPs) time dedicated to nebulized chronic obstructive pulmonary disease (COPD) therapy in inpatient and long-term care (LTC) settings. Using time and motion methodology, we quantified HCP time and opportunity costs (tim...
Autores principales: | De Cock, Erwin, Leung, Grace, Maclaine, Grant, Shah, Hemal, Kuhn, Brooks, Nichols, Bryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896414/ https://www.ncbi.nlm.nih.gov/pubmed/35246821 http://dx.doi.org/10.1007/s41030-022-00186-9 |
Ejemplares similares
-
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
por: Ganapathy, Vaidyanathan, et al.
Publicado: (2017) -
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD
por: Bollu, Vamsi, et al.
Publicado: (2013) -
Is nebulized saline a placebo in COPD?
por: Khan, Shahina Y, et al.
Publicado: (2004) -
Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010) -
A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)